Synbio Tech Inc. (1295.TWO) stock: key figures, P/E, revenue and dividend

Health Care · Taiwan · ISIN TW0001295004

Price
45.50 TWD
Market cap
1.57 bn TWD
P/E (2025)
8.94
P/S (2025)
1.51
Dividend yield
6.57 %
Net margin
16.94 %
Return on equity (ROE)
13.23 %
Return on assets (ROA)
5.70 %

Synbio Tech Inc. financials

Fiscal year20242025
Revenue989.48 m TWD1.04 bn TWD
Gross profit540.84 m TWD555.20 m TWD
Operating income209.40 m TWD198.41 m TWD
EBIT240.30 m TWD215.07 m TWD
Net income170.13 m TWD175.97 m TWD
Diluted EPS – continuing operations5.40 TWD5.09 TWD

Full history since 2020, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Synbio Tech Inc.

Synbio Tech Inc. manufactures and sells human healthcare products and probiotics for animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. The company also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional strain includes SynForU-MemoryUp, a solution for brain health; Lactobacillus plantarum TWK10 for exercise performance; ABKEFIR to improve digestive and promote human health; SynForU-ImmuUp for immune system; SynForU-GastroKeep, a stomach care probiotic; SynForU-HepaAid, a liver care probiotic; SynForU-HerCare, which inhibits the growth of fungal and bacterial pathogens, as well as maintains the vaginal microbiome in proper balance; multi strain probiotics; and postbiotics, which include LDL557, for modulate the immune system, reduce inflammation and joint pain, and M1, to support immune system. In addition, it offers GABAbiotics-Adaptogenic Postbiotics, Synbio-Oligo, and Yogurt Powder for food applications; pet health solutions, including SYNPET functional probiotics, SYNPET GO for muscle and joint care, SYNPET IMMU for skin and immunity care, SYNPET FIT for weight management, and SYNPET TRENAL for kidney health care and functional prebiotics. Further, the company provides SYNFERM Pigment, a lactobacillus strains that rapidly produce lactic acid; SYNFERM Feed for digestion and rapid nutrient uptake in poultry and livestock; and SYNFERM Corn Silage for ruminant animals with high digestible nutrients. Additionally, it offers SYNSEA FeedAd, a probiotic complex for aquatic livestock; and SYNSEA Clean EX for reduction in the concentrations of nitrites and ammonia in water, as well as antibiotic-free probiotic solutions for poultry, swine, aquaculture, ruminant, and pigmented plants. The company was incorporated in 2000 and is based in Kaohsiung, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.